Response to Secukinumab Shows Variations Across Psoriatic Arthritis Clusters
Researchers compared the effect of secukinumab on the quality of life of patients with very early and established psoriatic arthritis.
All articles by Alyssa Capel
Treatment With DMARDs Improves Cardiovascular Abnormalities in Early Rheumatoid Arthritis
Researchers determined the effect of disease-modifying antirheumatic drug therapy on patients with early rheumatoid arthritis with cardiovascular disease.
Similar Outcomes for Ischemic Stroke Hospitalizations With and Without Systemic Sclerosis
Researchers compared the hospitalization outcomes of patients with ischemic stroke with and without a secondary diagnosis of systemic sclerosis.
Interchangeability Observed Between 2 Measures of Minimal Disease Activity in Psoriatic Arthritis
Researchers assessed the interchangeability of 2 measures of minimal disease activity in psoriatic arthritis.
Acute Gout Prophylaxis Not Associated With Lower Gout Flare Risk After XOI Therapy
Researchers determined the real-world incidence of acute gout prophylaxis (AGP) while prescribing a xanthine oxidase inhibitor, and described the characteristics of AGP prescribing in reducing gout flares.
Assessing Rates and Risk Factors for Interstitial Lung Disease in Patients With Rheumatoid Arthritis
Researchers investigated the incidence rates of interstitial lung disease in patients with rheumatoid arthritis receiving tofacitinib and identified potential risk factors.
Anti-CD74 Antibodies Identified as Promising Tool to Support Diagnosis of Axial Spondyloarthritis
Researchers evaluated the role of anti-CD74 antibodies in the diagnosis of axial spondyloarthritis and their association with disease duration and activity.
Systemic Sclerosis Mortality Data Reveals Trends Over 48 Years
Researchers identified secular trends associated with systemic sclerosis mortality over 48 years.
Febuxostat Not Associated With Increased Risks for CVD Events, All-Cause Mortality in Gout
Researchers assessed whether febuxostat increased the risk of developing cardiovascular events, death from cardiac-cause, and all-cause mortalities.
Methotrexate Superior to Sulfasalazine as First-Line csDMARD Monotherapy in Patients With PsA
Researchers evaluated drug retention and predictors for drug retention among patients with psoriatic arthritis receiving first-line conventional synthetic DMARD monotherapy.
-
Loading...
-
Loading...
Next post in Spondyloarthritis
